AVTX vs PNC · P/E 0.0, rev $441.0K vs P/E 14, rev $23.10B
Avalo Therapeutics Inc (AVTX) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the AVTX and PNC stock pages for the full models.
Not investment advice.